These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 27835939

  • 1. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2016 Nov 11; 17(1):469. PubMed ID: 27835939
    [Abstract] [Full Text] [Related]

  • 2. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C, Zeldin Y, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2019 Mar 30; 20(1):135. PubMed ID: 30927912
    [Abstract] [Full Text] [Related]

  • 3. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
    Satish L, Gallo PH, Baratz ME, Johnson S, Kathju S.
    BMC Musculoskelet Disord; 2011 May 25; 12():113. PubMed ID: 21612641
    [Abstract] [Full Text] [Related]

  • 4. [Tofacitinib inhibits the transformation of lung fibroblasts into myofibroblasts through JAK/STAT3 pathway].
    He S, Chen X, Cheng Q, Zhu L, Zhang P, Tong S, Xue J, DU Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun 18; 56(3):505-511. PubMed ID: 38864137
    [Abstract] [Full Text] [Related]

  • 5. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
    Bi L, Huang Y, Li J, Yang X, Hou G, Zhai P, Zhang Q, Alhaji AA, Yang Y, Liu B.
    Nephron; 2022 Jun 18; 146(1):110-120. PubMed ID: 34724669
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA, Wang X, Payne WG, Ko F, Robson MC.
    J Surg Res; 2002 Apr 18; 103(2):146-52. PubMed ID: 11922728
    [Abstract] [Full Text] [Related]

  • 7. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
    Lv Q, Wang J, Xu C, Huang X, Ruan Z, Dai Y.
    Mol Med; 2020 May 24; 26(1):49. PubMed ID: 32448163
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
    Li N, Feng F, Wu K, Zhang H, Zhang W, Wang W.
    Biomed Pharmacother; 2019 Nov 24; 119():109387. PubMed ID: 31487583
    [Abstract] [Full Text] [Related]

  • 9. Verteporfin ameliorates fibrotic aspects of Dupuytren's disease nodular fibroblasts irrespective the activation state of the cells.
    Puerta Cavanzo N, Riesmeijer SA, Holt-Kedde IL, Werker PMN, Piersma B, Olinga P, Bank RA.
    Sci Rep; 2022 Aug 17; 12(1):13940. PubMed ID: 35977978
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH, Kim YM, Kim BS, Kim JH, Kim MB, Ko HC.
    Wound Repair Regen; 2014 Aug 17; 22(1):125-33. PubMed ID: 24471776
    [Abstract] [Full Text] [Related]

  • 11. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
    Ren M, Wang B, Zhang J, Liu P, Lv Y, Liu G, Jiang H, Liu F.
    Mol Med Rep; 2011 Aug 17; 4(3):561-7. PubMed ID: 21468608
    [Abstract] [Full Text] [Related]

  • 12. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
    Satish L, Palmer B, Liu F, Papatheodorou L, Rigatti L, Baratz ME, Kathju S.
    BMC Musculoskelet Disord; 2015 Jun 07; 16():138. PubMed ID: 26049932
    [Abstract] [Full Text] [Related]

  • 13. SPARC knockdown attenuated TGF-β1-induced fibrotic effects through Smad2/3 pathways in human pterygium fibroblasts.
    Fan J, Zhang X, Jiang Y, Chen L, Sheng M, Chen Y.
    Arch Biochem Biophys; 2021 Nov 30; 713():109049. PubMed ID: 34624278
    [Abstract] [Full Text] [Related]

  • 14. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
    Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C.
    Mol Vis; 2012 Nov 30; 18():1010-20. PubMed ID: 22550395
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
    Cho JS, Moon YM, Park IH, Um JY, Moon JH, Park SJ, Lee SH, Kang HJ, Lee HM.
    Clin Exp Allergy; 2012 Jun 30; 42(6):872-82. PubMed ID: 22239687
    [Abstract] [Full Text] [Related]

  • 16. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M, Mudera V.
    J Hand Surg Br; 2006 Oct 30; 31(5):473-83. PubMed ID: 16875762
    [Abstract] [Full Text] [Related]

  • 17. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E, Taurone S, Bardella L, Signore A, Pompili E, Sessa V, Chiappetta C, Fumagalli L, Di Gioia C, Pastore FS, Scarpa S, Artico M.
    Clin Sci (Lond); 2015 Oct 01; 129(8):711-20. PubMed ID: 26201022
    [Abstract] [Full Text] [Related]

  • 18. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
    Wu SB, Hou TY, Kau HC, Tsai CC.
    Biomolecules; 2021 Sep 29; 11(10):. PubMed ID: 34680057
    [Abstract] [Full Text] [Related]

  • 19. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
    Shin JM, Park JH, Park IH, Lee HM.
    Am J Rhinol Allergy; 2015 Sep 29; 29(6):408-13. PubMed ID: 26637578
    [Abstract] [Full Text] [Related]

  • 20. Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.
    Vi L, Njarlangattil A, Wu Y, Gan BS, O'Gorman DB.
    BMC Musculoskelet Disord; 2009 Jun 19; 10():72. PubMed ID: 19545383
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.